Since estriol binds primarily to estrogen receptor beta,16 this is consistent with preclinical data showing remyelination induced by estrogen receptor beta ligand treatment in MS preclinical models.17, 18, 19, 20, 21. Here, ESR2 is linked to myeloid sarcoma.